Deficits in GABAB receptor system in schizophrenia and mood disorders: A postmortem study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Postmortem and genetic studies have clearly demonstrated changes in GABAB receptors in neuropsychiatric disorders such as autism, bipolar disorder, major depression, and schizophrenia. Moreover, a number of recent studies have stressed the importance of cerebellar dysfunction in these same disorders. In the current study, we examined protein levels of the two GABAB receptor subunits GABBR1 and GABBR2 in lateral cerebella from a well-characterized cohort of subjects with schizophrenia (n=15), bipolar disorder (n=14), major depression (n=13) and healthy controls (n=12). We found significant reductions in protein for both GABBR1 and GABBR2 in lateral cerebella from subjects with schizophrenia, bipolar disorder and major depression when compared with controls. These results provide further evidence of GABAergic dysfunction in these three disorders as well as identify potential targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cerebellar cognitive affective syndrome
Schmahmann, J. (1998) · Brain · doi:10.1093/brain/121.4.561 · Cited by 3,230
Schmahmann, J. D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.005 · Cited by 1,625
Mueser, K. T., & McGurk, S. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16458-1 · Cited by 876
Schmahmann, J. D., & Pandya, D. N. (1997) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60346-3 · Cited by 774 · cited 1×
“Circuits connecting the cerebellumwith regions of the prefrontal cortex associated with executive function, verbal memory and language have been identified (Schmahmann and Pandya, 1997) and disruption of prefrontal–thalamic–cerebellar circuitry has been hypothesized to result in cognitive deficits associatedwith schiz…”
BackgroundAndreasen, N. C., O'Leary, D. S., Cizadlo, T., Arndt, S., Rezai, K., Ponto, L. L., Watkins, G. L., & Hichwa, R. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9985 · Cited by 625 · cited 4×
“Circuits connecting the cerebellum with regions of the prefrontal cortex associated with executive function, verbal memory and language have been identified (Schmahmann and Pandya, 1995) and disruption of prefrontal-thalamic-cerebellar circuitry has been hypothesized to result in cognitive deficits associated with sch…”
BackgroundInfluentialSequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006585 · Cited by 388 · cited 2×
“Altered expression of mRNA for GABBR1 and GABBR2 has been found in brains of subjects with major depression and victims of suicide (Klempan et al., 2009; Sequeira et al., 2009; Ghose et al., 2011) implicating GABAB receptor dysfunction in these disorders.”
BackgroundLiotti, M., Mayberg, H. S., McGinnis, S., Brannan, S. L., & Jerabek, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1830 · Cited by 331 · cited 4×
“…schizophrenia, bipolar disorder, and major depression (Andreasen et al., 1996; Baldaçara et al., 2008; Konarski et al., 2005; Krüger et al., 2003; Liotti et al., 2002; Loeber et al., 2002; Smith et al., 2002) and because of a lack of information regarding GABAB receptors in this region,…”
BackgroundInfluentialKlempan, T. A., Sequeira, A., Canetti, L., Lalovic, A., Ernst, C., ffrench-Mullen, J., & Turecki, G. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002110 · Cited by 294 · cited 5×
“…in disorders including autism (Fatemi et al., 2009; Oblak et al., 2010), bipolar disorder (Ishikawa et al., 2005), major depression (Ghose et al., 2011; Klempan et al., 2009; Sequiera et al., 2009) and schizophrenia (Ishikawa et al., 2005; Mizukami et al., 2000, 2002; Zai et al., 2005).”
BackgroundInfluentialExpression of GABAB Receptors Is Altered in Brains of Subjects with Autism
Fatemi, S. H., Folsom, T. D., Reutiman, T. J., & Thuras, P. D. (2009) · The Cerebellum · doi:10.1007/s12311-008-0075-3 · Cited by 227 · cited 7×
“Western blotting experiments for GABBR1 and GABBR2 were performed as previously described (Fatemi et al., 2009).”
BackgroundMethodSelf-citationDecreased GABA B receptors in the cingulate cortex and fusiform gyrus in Autism
Oblak, A. L., Gibbs, T. T., & Blatt, G. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06858.x · Cited by 203
Cited by
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00087 · Cited by 396
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
Demirtas-Tatlidede, A., Vahabzadeh-Hagh, A. M., & Pascual-Leone, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.020 · Cited by 236
“This location is further supported by the recent evidence stressing GABAergic dysfunction in cerebellum of patients with schizophrenia in addition to the previously demonstrated deficits in the prefrontal and cingulate cortices (Fatemi et al., 2011; Marín, 2012).”
Lecca, S., Pelosi, A., Tchenio, A., Moutkine, I., Lujan, R., Hervé, D., & Mameli, M. (2016) · Nature Medicine · doi:10.1038/nm.4037 · Cited by 176
Weber-Stadlbauer, U., Richetto, J., Labouesse, M. A., Bohacek, J., Mansuy, I. M., & Meyer, U. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.41 · Cited by 170
Meditation-Related Increases in GABAB Modulated Cortical Inhibition
Guglietti, C. L., Daskalakis, Z. J., Radhu, N., Fitzgerald, P. B., & Ritvo, P. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.08.005 · Cited by 83
Serpeloni, F., Radtke, K. M., Hecker, T., Sill, J., Vukojevic, V., Assis, S. G. D., Schauer, M., Elbert, T., & Nätt, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00269 · Cited by 77
“…1B (GABBR1), DTW Domain Containing 2 (DTWD2), and DISC1-Binding ZincFinger Protein (ZNF365), have been associated with multiple often comorbid disorders, including addiction, bipolar disorder, and schizophrenia (Ayyappan et al., 2009; Fatemi et al., 2011; Pan et al., 2013; Augier et al., 2018).”
BackgroundAberg, K. A., Dean, B., Shabalin, A. A., Chan, R. F., Han, L. K. M., Zhao, M., van Grootheest, G., Xie, L. Y., Milaneschi, Y., Clark, S. L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0247-6 · Cited by 73
“58 RUFY3 is implicated in the establishment of neuronal polarity 59, 60 and is necessary for normal axon elongation.”
Gaspar, H. A., & Breen, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-12325-3 · Cited by 67
Booker, S. A., Althof, D., Gross, A., Loreth, D., Müller, J., Unger, A., Fakler, B., Varro, A., Watanabe, M., Gassmann, M., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw090 · Cited by 25
Ritvo, P., Vora, K., Irvine, J., Mongrain, M., Azargive, S., Azam, M. A., Pirbaglou, M., Guglietti, C., Wayne, N., Perez, D., et al. (2013) · International Journal of Educational Psychology · doi:10.4471/ijep.2013.28 · Cited by 18
Family-based genome-wide association study of autism spectrum disorder in middle eastern families
Al-Sarraj, Y., Al-Dous, E., Taha, R. Z., Ahram, D., Alshaban, F., Tolfat, M., El-Shanti, H., & Albagha, O. M. E. (2021) · Genes · doi:10.3390/genes12050761 · Cited by 17
“This gene has been implicated in many neurodevelopmental and neuropsychiatric disorders [57,58].”
BackgroundAnderson, E. M., Loke, S., Wrucke, B., Engelhardt, A., Demis, S., O’Reilly, K., Hess, E., Wickman, K., & Hearing, M. C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01063-w · Cited by 16
Metadata
- Authors
- Fatemi, S. H., Folsom, T. D., & Thuras, P. D.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 128
- Issue
- 1-3
- Pages
- 37-43
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2027695575
- Cited by
- 138
- References
- 14
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.